American International Group, Inc. 2seventy Bio, Inc. Transaction History

American International Group, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$3.09 - $6.0 $655 - $1,272	-212 Reduced 0.85%	24,753 $132,000
Q4 2023 Feb 13, 2024	SELL	$1.57 - $4.58 $158 - $462	-101 Reduced 0.4%	24,965 $106,000
Q3 2023 Nov 13, 2023	BUY	$3.14 - $11.2 $2,797 - $9,979	891 Added 3.69%	25,066 $98,000
Q2 2023 Aug 04, 2023	BUY	$8.45 - $12.48 $51,798 - $76,502	6,130 Added 33.97%	24,175 $244,000
Q1 2023 May 12, 2023	BUY	$9.21 - $14.98 $3,315 - $5,392	360 Added 2.04%	18,045 $184,000
Q4 2022 Feb 10, 2023	SELL	$8.57 - $17.0 $548 - $1,088	-64 Reduced 0.36%	17,685 $165,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $3,140 - $4,385	250 Added 1.43%	17,749 $258,000
Q2 2022 Aug 12, 2022	BUY	$10.55 - $18.81 $62,044 - $110,621	5,881 Added 50.62%	17,499 $231,000
Q1 2022 May 13, 2022	SELL	$11.67 - $26.72 $4,049 - $9,271	-347 Reduced 2.9%	11,618 $198,000
Q4 2021 Feb 11, 2022	BUY	$13.77 - $42.56 $164,758 - $509,230	11,965 New	11,965 $307,000

122

48.2M

211K

9.7K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $187M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

Stay updated on American International Group, Inc. with notifications on news.